Highlights and Quick Summary
- Depreciation & Amortization Growth for the quarter ending June 30, 2021 was 726.19% (a 100.35% increase compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization Growth decreased by -1026.5%
- Annual Depreciation & Amortization Growth for 2021 was -4.17% (a -87.49% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2021 was -33.33% (a -2107.83% decrease from previous year)
- Annual Depreciation & Amortization Growth for 2020 was 1.66% (a -97.61% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization Growth of Biofrontera AG Sponsored ADR
Most recent Depreciation & Amortization Growthof BFAGY including historical data for past 10 years.Interactive Chart of Depreciation & Amortization Growth of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2021 | – | – | – | 726.19% | -4.17% |
2020 | – | – | – | 362.46% | 1.66% |
2019 | – | – | – | – | -2.56% |
2018 | – | – | – | – | -1.97% |
2017 | – | – | – | -87.9% | 7.38% |
2016 | -78.38% | – | – | – | 1.83% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic